Rankings
▼
Calendar
PASG (Passage Bio, Inc.) Stock Financials & Earnings | Market Cap Arena
PASG
Passage Bio, Inc.
Mkt Cap
$29M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$46M
EPS (TTM)
-$14.35
Free Cash Flow (TTM)
-$32M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$36M
Q2 23
$0
$0
-$25M
Q3 23
$0
$0
-$29M
Q4 23
$0
$0
-$18M
Q1 24
$0
$0
-$18M
Q2 24
$0
$0
-$17M
Q3 24
$0
$0
-$21M
Q4 24
$0
-$719K
-$14M
Q1 25
$0
$0
-$16M
Q2 25
$0
-$200K
-$10M
Q3 25
$0
$0
-$9M
Q4 25
$0
$200K
-$14M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$22M
-$22M
Q2 23
-$17M
-$17M
Q3 23
-$19M
-$19M
Q4 23
-$20M
-$20M
Q1 24
-$19M
-$19M
Q2 24
-$13M
-$13M
Q3 24
-$7M
-$7M
Q4 24
-$8M
-$8M
Q1 25
-$14M
-$14M
Q2 25
-$6M
-$6M
Q3 25
-$5M
-$5M
Q4 25
-$6M
-$6M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$26K
Q2 23
$103K
Q3 23
$4K
Q4 23
$13K
Q1 24
$0
Q2 24
$0
Q3 24
$20K
Q4 24
$14K
Q1 25
$0
Q2 25
$0
Q3 25
$0
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
-16.2%
Q2 23
—
-36.2%
Q3 23
—
+4.2%
Q4 23
—
-34.7%
Q1 24
—
-49.7%
Q2 24
—
-31.6%
Q3 24
—
-27.8%
Q4 24
—
-22.6%
Q1 25
—
-8.8%
Q2 25
—
-40.5%
Q3 25
—
-58.2%
Q4 25
—
-3.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$3M
—
Q2 23
$4M
—
Q3 23
$3M
—
Q4 23
$2M
—
Q1 24
$2M
—
Q2 24
$2M
—
Q3 24
$1M
—
Q4 24
$1M
—
Q1 25
$858K
—
Q2 25
$923K
—
Q3 25
$0
—
Q4 25
$609K
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$17M
$8M
—
Q2 23
$17M
$8M
—
Q3 23
$15M
$8M
—
Q4 23
$12M
$6M
—
Q1 24
$12M
$7M
—
Q2 24
$10M
$7M
—
Q3 24
$9M
$7M
—
Q4 24
$10M
—
$4M
Q1 25
$8M
$6M
—
Q2 25
$6M
$5M
—
Q3 25
$4M
$4M
—
Q4 25
$5M
$5M
—
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$33M
$134M
$168M
Q2 23
$30M
$121M
$151M
Q3 23
$34M
$99M
$133M
Q4 23
$22M
$93M
$114M
Q1 24
$37M
$68M
$105M
Q2 24
$25M
$67M
$92M
Q3 24
$32M
$53M
$85M
Q4 24
$38M
$39M
$77M
Q1 25
$63M
$0
$63M
Q2 25
$58M
$0
$58M
Q3 25
$53M
$0
$53M
Q4 25
$46M
$0
$46M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
3M
+0.0%
Q2 23
3M
+0.1%
Q3 23
3M
+0.2%
Q4 23
3M
+0.3%
Q1 24
3M
+2.5%
Q2 24
3M
+9.6%
Q3 24
3M
+0.1%
Q4 24
3M
+0.5%
Q1 25
3M
+0.1%
Q2 25
3M
+2.0%
Q3 25
3M
+0.0%
Q4 25
3M
+0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
$0
74
FY 21
$0
133
FY 22
$0
85
FY 23
$0
58
FY 24
$0
60
FY 25
$0
200K
marketcaparena.com